Glen Lutchman
Publication Details
-
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
Aliment Pharmacol Ther. 2009; (2): 172-82
Non-alcoholic steatohepatitis (NASH) is a form of progressive fatty liver disease that is strongly associated with insulin resistance, which suggests that insulin sensitizing agents such as metformin may be beneficial for NASH.
Help